Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder

Medical Research ◽

Research Council ◽

Low Dose ◽

Medical Research Council ◽

Phase Ii Study ◽

Locally Advanced ◽

Transitional Cell ◽

Primary Treatment ◽

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study

British Journal of Cancer ◽

10.1038/bjc.1998.629 ◽

1998 ◽

Vol 78 (8) ◽

pp. 1067-1075 ◽

Cited By ~ 66

Author(s):

GM Mead ◽

◽

M Russell ◽

P Clark ◽

SJ Harland ◽

...

Keyword(s):

Prognostic Factors ◽

Medical Research ◽

Randomized Trial ◽

Cell Carcinoma ◽

Research Council ◽

Medical Research Council ◽

Transitional Cell

Neoadjuvant Intra-Arterial Doxorubicin Chemotherapy in Combination with Low Dose Radiotherapy for the Treatment of Locally Advanced Transitional Cell Carcinoma of the Bladder

The Journal of Urology ◽

10.1016/s0022-5347(17)32740-4 ◽

1994 ◽

Vol 152 (2 Part 1) ◽

pp. 362-366 ◽

Cited By ~ 9

Author(s):

Yoshiteru Sumiyoshi ◽

Kinya Yokota ◽

Masanori Akiyama ◽

Yoshio Inoue ◽

Fumio Yoneda ◽

...

Keyword(s):

Cell Carcinoma ◽

Low Dose ◽

Locally Advanced ◽

Transitional Cell ◽

Low Dose Radiotherapy ◽

Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: A phase II study

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/j.1743-7563.2012.01554.x ◽

2012 ◽

Vol 9 (1) ◽

pp. 60-65 ◽

Cited By ~ 2

Author(s):

Amal Halim ◽

Niveen Abotouk

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Transitional Cell ◽

Second Line ◽

Second Line Chemotherapy ◽

Carcinoma Of The Bladder ◽

Line Chemotherapy

A Phase-II Study of Neoadjuvant Chemotherapy in T(3)-4N(0)-XM(0) Transitional Cell Carcinoma of the Bladder: A Preliminary Analysis

European Urology ◽

10.1159/000473035 ◽

1988 ◽

Vol 14 (1) ◽

pp. 24-26

Author(s):

D. Jacqmin ◽

R.R. Hall ◽

M. de Pauw ◽

T.A.W. Splinter ◽

F.H. Schröder ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Cell Carcinoma ◽

Phase Ii ◽

Preliminary Analysis ◽

Phase Ii Study ◽

Transitional Cell ◽

A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2011.07.015 ◽

2013 ◽

Vol 31 (6) ◽

pp. 878-882 ◽

Cited By ~ 2

Author(s):

Madhumita Bhattacharyya ◽

Tom Powles ◽

Katherine Mutsvangwa ◽

Peter Wilson ◽

Timothy Oliver ◽

...

Keyword(s):

Cell Carcinoma ◽

Folinic Acid ◽

Phase Ii ◽

Phase Ii Study ◽

Transitional Cell ◽

A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4594 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4594-4594 ◽

Cited By ~ 24

Author(s):

C. Wülfing ◽

J.-P. Machiels ◽

D. Richel ◽

M.-O. Grimm ◽

U. Treiber ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Transitional Cell ◽

Open Label ◽

Open Label Phase

Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma (TCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e15535 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e15535-e15535

Author(s):

Emmanuel Seront ◽

Sylvie Rottey ◽

Bertrand Filleul ◽

Phillipe Glorieux ◽

Jean Charles. Goeminne ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Mtor Inhibitor ◽

Phase Ii Study ◽

Locally Advanced ◽

Transitional Cell ◽

Mammalian Target Of Rapamycin ◽

Target Of Rapamycin

Phase II Study of Carboplatin in Locally Advanced and Metastatic Transitional Cell Carcinoma of the Urinary Bladder

British Journal of Urology ◽

10.1111/j.1464-410x.1989.tb05318.x ◽

1989 ◽

Vol 64 (6) ◽

pp. 604-607 ◽

Cited By ~ 23

Author(s):

N. K. RAABE ◽

SOPHIE D. FOSSÅ ◽

G. PARØ

Keyword(s):

Urinary Bladder ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Transitional Cell

A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder

European Journal of Cancer and Clinical Oncology ◽

10.1016/0277-5379(89)90036-9 ◽

1989 ◽

Vol 25 (2) ◽

pp. 391-392 ◽

Cited By ~ 6

Author(s):

G. Blackledge ◽

J.T. Roberts ◽

S. Kaye ◽

R. Taylor ◽

J. Williams ◽

...

Keyword(s):

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Transitional Cell ◽

IFOSFAMIDE, PACLITAXEL, AND CISPLATIN (ITP) CHEMOTHERAPY FOR LOCALLY ADVANCED, UNRESECTABLE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

The Journal of Urology ◽

10.1097/00005392-199904020-00054 ◽

1999 ◽

pp. 263

Author(s):

Paul M Dodd ◽

John A McCaffrey ◽

Susan Hilton ◽

Harry Herr ◽

Dean F Bajorin

Keyword(s):

Cell Carcinoma ◽

Locally Advanced ◽

Transitional Cell ◽